中国当代医药
中國噹代醫藥
중국당대의약
PERSON
2015年
16期
129-131
,共3页
阿托伐他汀%糖尿病肾病%血脂异常%疗效分析
阿託伐他汀%糖尿病腎病%血脂異常%療效分析
아탁벌타정%당뇨병신병%혈지이상%료효분석
Atorvastatin%Diabetic nephropathy%Dyslipidemia%Curative effect analysis
目的:探讨阿托伐他汀治疗糖尿病肾病血脂异常的临床效果。方法选取2012年1月~2014年1月在本院就诊的86例糖尿病肾病合并血脂异常患者作为研究对象,随机分为治疗组和对照组,各43例。对照组给予常规治疗,治疗组在对照组的基础上给予阿托伐他汀,连用3个月。比较两组治疗前后的尿白蛋白排泄率(UAER)、血清胆固醇(TC)、三酰甘油(TG)、低密度脂蛋白胆固醇(LDL-C)、高敏C反应蛋白(hs-CRP)水平以及疗效。结果观察组的总有效率为88.3%,显著高于对照组的65.1%,差异有统计学意义(P<0.05)。观察组的TC、LDL、UAER水平显著高于对照组,差异有统计学意义(P<0.05)。观察组的TG、hs-CRP水平与对照组比较,差异无统计学意义(P>0.05)。结论阿托伐他汀治疗糖尿病肾病血脂异常效果显著,值得临床推广应用。
目的:探討阿託伐他汀治療糖尿病腎病血脂異常的臨床效果。方法選取2012年1月~2014年1月在本院就診的86例糖尿病腎病閤併血脂異常患者作為研究對象,隨機分為治療組和對照組,各43例。對照組給予常規治療,治療組在對照組的基礎上給予阿託伐他汀,連用3箇月。比較兩組治療前後的尿白蛋白排洩率(UAER)、血清膽固醇(TC)、三酰甘油(TG)、低密度脂蛋白膽固醇(LDL-C)、高敏C反應蛋白(hs-CRP)水平以及療效。結果觀察組的總有效率為88.3%,顯著高于對照組的65.1%,差異有統計學意義(P<0.05)。觀察組的TC、LDL、UAER水平顯著高于對照組,差異有統計學意義(P<0.05)。觀察組的TG、hs-CRP水平與對照組比較,差異無統計學意義(P>0.05)。結論阿託伐他汀治療糖尿病腎病血脂異常效果顯著,值得臨床推廣應用。
목적:탐토아탁벌타정치료당뇨병신병혈지이상적림상효과。방법선취2012년1월~2014년1월재본원취진적86례당뇨병신병합병혈지이상환자작위연구대상,수궤분위치료조화대조조,각43례。대조조급여상규치료,치료조재대조조적기출상급여아탁벌타정,련용3개월。비교량조치료전후적뇨백단백배설솔(UAER)、혈청담고순(TC)、삼선감유(TG)、저밀도지단백담고순(LDL-C)、고민C반응단백(hs-CRP)수평이급료효。결과관찰조적총유효솔위88.3%,현저고우대조조적65.1%,차이유통계학의의(P<0.05)。관찰조적TC、LDL、UAER수평현저고우대조조,차이유통계학의의(P<0.05)。관찰조적TG、hs-CRP수평여대조조비교,차이무통계학의의(P>0.05)。결론아탁벌타정치료당뇨병신병혈지이상효과현저,치득림상추엄응용。
Objective To explore the clinical effect of atorvastatin in the treatment of dyslipidemia of diabetic nephropathy. Methods 86 patients with diabetes nephropathy and dyslipidemia from January 2012 to January 2014 in our hospital were selected and randomly divided into the observation group and the control group,43 cases in each group.The control group was given conventional treatment,the observation group were given atorvastatin on the basis of the control group for 3 months.The level of urinary albumin excretion rate (UAER),total cholesterol (TC),triglyceride (TG),low density lipoprotein cholesterin (LDL-C),high-sensitivity C-reactive protein (hs-CRP) and the curative effect before and after treatment in two groups was compared. Results The total effective rate of the observation was 88.3%, which was higher than 65.1% of the control group,with significant difference (P<0.05).The level of TC,LDL and UAER in the observation group was higher than that in the control group,with significant difference(P<0.05). There was no sig-nificant difference between the TG,hs-CRP in two groups (P>0.05). Conclusion The effect of atorvastatin in the treat-ment of dyslipidemia of diabetic nephropathy is significant,it is worthy of clinical promotion and application.